Senseonics Holdings (Senseonics Holdings) Interest Expense : $-8.50 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Senseonics Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Senseonics Holdings's interest expense for the three months ended in Mar. 2024 was $ -2.05 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-8.50 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Senseonics Holdings's Operating Income for the three months ended in Mar. 2024 was $ -18.23 Mil. Senseonics Holdings's Interest Expense for the three months ended in Mar. 2024 was $ -2.05 Mil. Senseonics Holdings did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Senseonics Holdings Interest Expense Historical Data

The historical data trend for Senseonics Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senseonics Holdings Interest Expense Chart

Senseonics Holdings Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-11.80

-16.17

-16.72

-18.70

-11.11

Senseonics Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-4.65	-2.31	-2.43	-1.72	-2.05

Senseonics Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.50 Mil.

Senseonics Holdings (AMEX:SENS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Senseonics Holdings's Interest Expense for the three months ended in Mar. 2024 was $-2.05 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-18.23 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $40.08 Mil.

Senseonics Holdings's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Senseonics Holdings did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Senseonics Holdings (Senseonics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senseonics Holdings Inc (AMEX:SENS) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

6L6:Germany 6L6:Germany

Address

20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005

Website

https://www.senseonics.com

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of the glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Executives

Sharon Larkin	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Douglas A Roeder	director	160 BOVET RD, SUITE 408, C/O DELPHI VENTURES, SAN MATEO CA 94402
Frederick T. Sullivan	officer: Chief Financial Officer	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Mukul Jain	officer: VP Operations, Qual & Reg	20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Edward Fiorentino	director	1350 KENNICOTT DRIVE, LAKE FOREST IL 60045
Mirasol Panlilio	officer: VP Global Sales & Marketing	20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Timothy T Goodnow	director, officer: President & Chief Exec Officer	20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Francine Kaufman	officer: Chief Medical Officer	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Kenneth L Horton	officer: GC & Corp. Development Advisor	VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE MA 02139
Nick B. Tressler	officer: Chief Financial Officer	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 208786
Anthony R. Raab	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
John Marotta	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Stephen P Defalco	director	ONE EXETER STREET, BOSTON MA 02116
Douglas S Prince	director	20 TILESTON STREET, PH4, BOSTON MA 02113
Edelman Steven	director	C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876